Mainz Biomed’s Best-In-Class Cancer Screening Diagnostics Puts Explosive Growth In Its Crosshairs ($MYNZ)
Silo Pharma May Change The Treatment Landscape For Neurological Disorders, Merging Traditional And Psychedelic Compounds ($SILO)
KULR Technology Assets And Contract Pipeline Should Have Its Stock Running With The Bulls…Here’s Why ($KULR)
Mainz Biomed Stock Is Catching A Bid; Cancer Screening Diagnostics Tap Into Billion Dollar Potential ($MYNZ)
Mainz Biomed Decouples From Weaker Markets, Investors Focused On Best-In-Class Cancer Screening Diagnostics ($MYNZ)
Cosmos Health Is Getting Bigger, Signs Distribution Deal To Expedite Growth In Germany And Austria ($COSM)
Recharge Resources Receives Approvals To Drill At Pocitos 1 Project; Follows Expedited Development At Georgia Lake And West Lithium Properties ($RECHF)
Cosmos Health Stock Jumps; Fueled By Posting Triple- Digit Percentage EBITDA Increase In 1H/2022 ($COSM)
